Newly-merged Ardena buys Dutch bio lab

By Flora Southey contact

- Last updated on GMT


Related tags: Clinical trial, Pharmacology, Netherlands

Recently-formed CDMO Ardena has purchased bioanalytical contract laboratory ABL in Assen, the Netherlands.

According to CEO Harry Christiaens, the acquisition – which increases Ardena’s scientists to 125 – enables the firm to provide bioanalytical services.

“With ABL’s expertise, we can now support sponsors with bioanalytical and drug discovery services to help them reach important pre-clinical and clinical milestones,” ​he said.

Pharmavize x Crystallics

Ardena, launched earlier this month, is the product of a merger between Belgium-based Pharmavize and Dutch firm Crystallics.

“We made the decision to combine the specialist capabilities of both Pharmavize and Crystallics last year so that we would be better placed to help our customers navigate the hurdles and pitfalls of early phase drug development.”

“Our focus is to create strong formulations and regulatory-compliant drug products for clients planning early phase clinical trials,” ​said Christiaens.

The Belgium-headquartered firm offers solid-state chemistry, analytical and formulation development, and early-phase clinical supply manufacturing, and has facilities in Amsterdam and Assen in the Netherlands, and Ghent, Belgium.

Christiaens said Ardena will continue to expand in line with its ‘buy and build’ strategy.

“New acquisitions will follow soon,” ​he said. 

Related news

Show more

Related products

show more

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

Related suppliers

Follow us


View more